Panacea Biotec has informed that meeting of the Board of Directors of the Company is scheduled on 13/02/2024, to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31, 2023. The trading window of the Company shall remain closed for all Designated Persons of the Company till February 15, 2024 and the same will re-open from February 16, 2024.
The above information is a part of company’s filings submitted to BSE.
